Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
10
pubmed:dateCreated
2006-9-14
pubmed:abstractText
Carbon monoxide (CO), a byproduct of heme catalysis, was shown to have potent cytoprotective and anti-inflammatory effects. In vivo recipient CO inhalation at low concentrations prevented ischemia/reperfusion (I/R) injury associated with small intestinal transplantation (SITx). This study examined whether ex vivo delivery of CO in University of Wisconsin (UW) solution could ameliorate intestinal I/R injury. Orthotopic syngenic SITx was performed in Lewis rats after 6 h cold preservation in control UW or UW that was bubbled with CO gas (0.1-5%) (CO-UW). Recipient survival with intestinal grafts preserved in 5%, but not 0.1%, CO-UW improved to 86.7% (13/15) from 53% (9/17) with control UW. At 3 h after SITx, grafts stored in 5% CO-UW showed improved intestinal barrier function, less mucosal denudation and reduced inflammatory mediator upregulation compared to those in control UW. Preservation in CO-UW associated with reduced vascular resistance (end preservation), increased graft cyclic guanosine monophosphate levels (1 h), and improved graft blood flow (1 h). Protective effects of CO-UW were reversed by ODQ, an inhibitor of soluble guanylyl cyclase. In vitro culture experiment also showed better preservation of vascular endothelial cells with CO-UW. The study suggests that ex vivo CO delivery into UW solution would be a simple and innovative therapeutic strategy to prevent transplant-induced I/R injury.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
1600-6135
pubmed:author
pubmed:issnType
Print
pubmed:volume
6
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2243-55
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:16827783-Adenosine, pubmed-meshheading:16827783-Allopurinol, pubmed-meshheading:16827783-Animals, pubmed-meshheading:16827783-Antimetabolites, pubmed-meshheading:16827783-Carbon Monoxide, pubmed-meshheading:16827783-Disease Models, Animal, pubmed-meshheading:16827783-Glutathione, pubmed-meshheading:16827783-Graft Survival, pubmed-meshheading:16827783-Insulin, pubmed-meshheading:16827783-Intestinal Mucosa, pubmed-meshheading:16827783-Intestine, Small, pubmed-meshheading:16827783-Male, pubmed-meshheading:16827783-Microscopy, Electron, Transmission, pubmed-meshheading:16827783-Organ Preservation, pubmed-meshheading:16827783-Organ Preservation Solutions, pubmed-meshheading:16827783-Organ Transplantation, pubmed-meshheading:16827783-Raffinose, pubmed-meshheading:16827783-Rats, pubmed-meshheading:16827783-Rats, Inbred Lew, pubmed-meshheading:16827783-Reperfusion Injury, pubmed-meshheading:16827783-Treatment Outcome
pubmed:year
2006
pubmed:articleTitle
Ex vivo application of carbon monoxide in University of Wisconsin solution to prevent intestinal cold ischemia/reperfusion injury.
pubmed:affiliation
Thomas E. Starzl Transplantation Institute, University of Pittsburgh, Pennsylvania, USA. anakao@imap.pitt.edu
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural